Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Temporal Dynamics of Multiple Sclerosis Risk: Integrating Genetic Susceptibility and Early-Life Exposures
Genetics
Temporal Dynamics of Multiple Sclerosis Risk: Integrating Genetic Susceptibility and Early-Life Exposures

19, Mar 2026

2
Temporal Dynamics of Multiple Sclerosis Risk: Integrating Genetic Susceptibility and Early-Life Exposures
Genetics
Decoding Biological Complexity: An Integrative Analysis of Molecular Systems

17, Mar 2026

3
Decoding the Genetic Architecture of Multiple Sclerosis: From Disease Susceptibility to Clinical Severity
Genetics
Decoding the Genetic Architecture of Multiple Sclerosis: From Disease Susceptibility to Clinical Severity

17, Mar 2026

4
Genetic and Gene Expression Signatures in Multiple Sclerosis: Insights from Modern Genomic Research
Genetics
Genetic and Gene Expression Signatures in Multiple Sclerosis: Insights from Modern Genomic Research

16, Mar 2026

5
Polygenic Risk Scores Reveal Genetic Stratification of Lifetime Multiple Sclerosis Risk
Genetics
Polygenic Risk Scores Reveal Genetic Stratification of Lifetime Multiple Sclerosis Risk

15, Mar 2026

Categories:
Genetics
Moving Beyond "One Drug Fits All" in Multiple Sclerosis: The Dawn of Personalized Medicine
Genetics
Moving Beyond "One Drug Fits All" in Multiple Sclerosis: The Dawn of Personalized Medicine

27, Apr 2025

Decoding MS Treatment Response: Could Our Genes Hold the Key to Better Outcomes with Glatiramer Acetate?
Genetics
Decoding MS Treatment Response: Could Our Genes Hold the Key to Better Outcomes with Glatiramer Acetate?

28, Apr 2025

Multiple Sclerosis Treatment Response and the Role of Genetic Variations
Genetics
Multiple Sclerosis Treatment Response and the Role of Genetic Variations

29, Apr 2025

Genetic Variations Influencing Glatiramer Acetate Response in Multiple Sclerosis: A Pharmacogenomic Perspective
Genetics
Genetic Variations Influencing Glatiramer Acetate Response in Multiple Sclerosis: A Pharmacogenomic Perspective

30, Apr 2025